Abbas Abdollahi

Summary

Publications

  1. ncbi request reprint LOT1 (ZAC1/PLAGL1) and its family members: mechanisms and functions
    Abbas Abdollahi
    Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University, Philadelphia, Pennsylvania 19122, USA
    J Cell Physiol 210:16-25. 2007
  2. ncbi request reprint Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer
    Dusica Cvetkovic
    Ovarian Cancer Program, Department of Medical Oncology, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA, USA
    Gynecol Oncol 95:449-55. 2004
  3. ncbi request reprint LOT1 (PLAGL1/ZAC1), the candidate tumor suppressor gene at chromosome 6q24-25, is epigenetically regulated in cancer
    Abbas Abdollahi
    Ovarian Cancer Program, Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    J Biol Chem 278:6041-9. 2003
  4. ncbi request reprint Identification of epidermal growth factor-responsive genes in normal rat ovarian surface epithelial cells
    Abbas Abdollahi
    Ovarian Cancer Program, Department of Medical Oncology, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111 2497, USA
    Biochem Biophys Res Commun 307:188-97. 2003
  5. ncbi request reprint Identification of interleukin 8 as an inhibitor of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in the ovarian carcinoma cell line OVCAR3
    Touraj Abdollahi
    Department of Biochemistry and Molecular Pharmacology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Cancer Res 63:4521-6. 2003

Collaborators

Detail Information

Publications5

  1. ncbi request reprint LOT1 (ZAC1/PLAGL1) and its family members: mechanisms and functions
    Abbas Abdollahi
    Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University, Philadelphia, Pennsylvania 19122, USA
    J Cell Physiol 210:16-25. 2007
    ....
  2. ncbi request reprint Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer
    Dusica Cvetkovic
    Ovarian Cancer Program, Department of Medical Oncology, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA, USA
    Gynecol Oncol 95:449-55. 2004
    ..In this study, we evaluated the LOT1 gene expression and allelic deletion in the tumor tissues in order to provide additional evidence to support the gene's potential role in cancer...
  3. ncbi request reprint LOT1 (PLAGL1/ZAC1), the candidate tumor suppressor gene at chromosome 6q24-25, is epigenetically regulated in cancer
    Abbas Abdollahi
    Ovarian Cancer Program, Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    J Biol Chem 278:6041-9. 2003
    ....
  4. ncbi request reprint Identification of epidermal growth factor-responsive genes in normal rat ovarian surface epithelial cells
    Abbas Abdollahi
    Ovarian Cancer Program, Department of Medical Oncology, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111 2497, USA
    Biochem Biophys Res Commun 307:188-97. 2003
    ....
  5. ncbi request reprint Identification of interleukin 8 as an inhibitor of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in the ovarian carcinoma cell line OVCAR3
    Touraj Abdollahi
    Department of Biochemistry and Molecular Pharmacology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Cancer Res 63:4521-6. 2003
    ..The data suggest a potentially important role of IL-8 in protecting ovarian cancer cells from TRAIL-mediated apoptosis and signify a new potential chemotherapeutic target to augment TRAIL therapy...